J+D, Pharma Forecasting Experts Partner with Epiphany, Oncology Data Experts

13th November 2018
J+D have brought several innovations to market this year including Online Training, theHub, and FC+ software. Onco+ is the very latest innovation from the Pharma Forecasting Company, established over 10 years ago. Onco+, part of the FC+ portfolio has been created to help clients build…
Read More

J+D grows in the Middle East and partners with Curis Health

24th October 2018
J+D, the pharmaceutical forecasting experts are delighted to announce their partnership with Curis Health, MEA. Curis Health are keen to utilise J+D’s expertise and tools and J+D will have greater access to the Middle East markets. J+D was set up over 10 years ago based…
Read More

The First Online Pharma Forecasting Training brought to the market by J+D

18th October 2018
Following the success of J+D’s face to face pharma forecasting training workshops, they have digitalised the format. This is the first ever online pharmaceutical forecasting training course of its kind. “At J+D we love to educate, support and inject the passion we have for forecasting…
Read More

theHub is here – the place for all your forecasting needs

2nd October 2018
Today J+D is celebrating the launch of theHub. theHub is a brand-new innovation that houses everything anyone involved in forecasting could need. theHub is accessible 24/7 for people to create, build and learn about forecasting at any time any place and any pace. theHub includes…
Read More

David Baker Joins J+D from Fresenius Kabi

1st October 2018
David Baker joins J+D as a Business Consultant to support clients with ‘Bespoke’ complex model development, FC+ ongoing software development and FC365, Sharepoint and PowerBI technologies. David is a fully trained Pharmacist with academic, hospital and community experience. In his previous role for Fresenius Kabi,…
Read More

A Year of Change at J+D – new branding, products and website

25th September 2018
The ‘shape’ of J+D (previously J&D Consulting) has changed in the last 9 months with several product innovations, new branding and a new website greeting the market. Traditionally, for the last 10 years, J+D have provided Bespoke consultancy forecasting solutions for global and local affiliates.…
Read More

Something beautiful in forecasting is about to happen

2nd July 2018
J+D are very proud to announce the launch of their latest pharmaceutical forecasting innovation, FC+. FC+ is a unique forecasting software for pharma and bio tech companies. Long gone are the days of slow, clunky, difficult to read forecasting models. FC+ is a responsive, intuitive…
Read More

J+D Consulting welcome Sophie Adlard to the Team

10th July 2017
J+D Consulting are thrilled that Sophie Adlard, Business Analyst has joined the expanding J+D team. Sophie’s strong organisational skill, analytical background in collating secondary data plus, her experience in statistics will help our clients to manage their information more effectively. David James founding Director believes…
Read More

J+D Expands into Japan

27th June 2017
J+D Consulting are pleased to announce their new partnership with Seigo Maeda, founder of SDMJ Consulting in Japan (previously president of Datamonitor Japan for 17 years), who will support J+D’s continued Global expansion into the Japanese market. David James (MD, J+D Consulting) said yesterday “We…
Read More

The Fundamental Pillars that Support Good Forecasting

21st June 2017
The Context Here at J+D we create 100’s of strategic forecasting and operational planning models for many of the largest pharmaceutical companies year on year. These figures have increased consistently, certainly in the last 3-5 years; as scrutiny from pharmaceutical investors puts increasing pressure on revenue generation…
Read More

J+D delivers impactful forecasting training at EphMRA 2016 Conference

17th July 2016
We were delighted to be a part of EphMRA’s Flagship Annual Conference this year in Frankfurt. As a thought leader in Forecasting, David James (CEO of J+D) is always pleased to offer advice and support to others in the Pharma Industry regarding the importance of…
Read More